GeneSet Information

Tier IV GS410637 • Oxycodone-induced (0.25mg/kg) differential expression of axon guidance and integrin genes in the mouse nucleus accumbens_qvalue

DESCRIPTION:

Total RNA from the NAc and CPu were isolated from 12 adult male C57BL/6J mice (11 weeks old) within 1 h after the last session of oxycodone in a 14-day self-administration paradigm (4h/day, 0.25 mg/kg/infusion, FR1) or from yoked saline controls (6 oxycodone and 6 yoked saline controls). RNA-Seq libraries were prepared using Illumina's TruSeq® Stranded Total RNA LT kit. An Illumina HiSeq 2500 apparatus was used to obtain 100 bp single end reads for samples from the nucleus accumbens, whereas Illumina HiSeq 2000 was used to obtain 100 bp paired-end reads for samples from the CPu. The reads were aligned to the mouse reference genome (version mm10) using STAR. Aligned reads were then summarized through featureCounts with the gene model from Ensemble (Mus_musculus GRCm38.75.gtf) at gene level. Gene expressions were examined using using the miRNeasy Kit (Qiagen, Valencia, CA). Agilent 6000 RNA Nano Chips were used to examine the integrity of RNA in samples. DESeq2 was applied to the counts of protein coding genes to estimate the fold change between the treatment groups. False Discovery Rate (FDR) q < 0.1 were used to select genes that have a significant expression change. In the CPu, data from one saline control, and from one oxycodone-treated animals were excluded from downstream analysis. In the NAc, data from one oxycodone-treated animal was excluded from the downstream analysis. Statistical significance and fold change of oxycodone-induced alterations in expression of 32 axon guidance-related genes (integrins, semaphorins and ephrins, and their receptors) were extracted from the total list of differentially expressed genes in the RNA-seq data for the NAc and CPu in this study. To examine whether DE axon guidance genes may produce their effect in a cell type specific manner, we have studied potential enrichment in transcripts of the axon guidance genes in specific cell types such as astrocytes, neurons, microglial and endothelial cells. Publicly available RNA-Seq transcriptome data were downloaded from GEO (GSE52564). For each gene of integrin, semaphorin and ephrin gene families, that had a significant change (FDR < 0.1) in either NAc or CPu, expression fold change of each cell type was calculated as described recently (Table 2). For selection of a subset of genes related to axon guidance pathway, REACTOME was used. All genes from results are shown. From supplementary table 1s.

LABEL:

Axon guidance and integrin DEG mouse Nac 0.25mg/kg oxycodone vs control_qvalue

SCORE TYPE:

Q-Value

THRESHOLD:

<= 0.1

GENES IN THRESHOLD:

28

DATE ADDED:

2025-02-28

DATE UPDATED:

2025-07-03

SPECIES:

AUTHORS:

Vadim Yuferov, Yong Zhang, Yupu Liang, Connie Zhao, Matthew Randesi, Mary J Kreek

TITLE:

Oxycodone Self-Administration Induces Alterations in Expression of Integrin, Semaphorin and Ephrin Genes in the Mouse Striatum.

JOURNAL:

Frontiers in psychiatry None 2018, Vol 9, pp. 257

ABSTRACT:

Oxycodone is one a commonly used medication for pain, and is also a widely abused prescription opioid, like other short-acting MOPr agonists. Neurochemical and structural adaptations in brain following chronic MOPr-agonist administration are thought to underlie pathogenesis and persistence of opiate addiction. Many axon guidance molecules, such as integrins, semaphorins, and ephrins may contribute to oxycodone-induced neuroadaptations through alterations in axon-target connections and synaptogenesis, that may be implicated in the behaviors associated with opiate addiction. However, little is known about this important area. The aim of this study is to investigate alterations in expression of selected integrin, semaphorin, ephrins, netrin, and slit genes in the nucleus accumbens (NAc) and caudate putamen (CPu) of mice following extended 14-day oxycodone self-administration (SA), using RNAseq. PUBMED: 29946272
Find other GeneSets from this publication

Annotation Information

No sequence read archive data associated with this GeneSet.


Oxycodone (D010098)
Endothelial Cells (D042783)
Behavior (D001519)
Putamen (D011699)
Integrins (D016023)
Astrocytes (D001253)
Opioid-Related Disorders (D009293)
Gene Expression (D015870)
Proteins (D011506)
Therapeutics (D013812)
Neurons (D009474)
Ephrins (D036342)
Nucleus Accumbens (D009714)
Opiate Alkaloids (D053610)
Analgesics, Opioid (D000701)
Semaphorins (D039961)
caudate-putamen (MA:0000893)
accumbens nucleus (MA:0000892)
addiction (MP:0002555)
killing by symbiont of host cells (GO:0001907)
stem cell factor receptor activity (GO:0005020)
modulation by symbiont of host defense response (GO:0052031)
ephrin receptor binding (GO:0046875)
modification by symbiont of host morphology or physiology (GO:0044003)
axon guidance (GO:0007411)
synapse assembly (GO:0007416)
cytolysis by symbiont of host cells (GO:0001897)
nascent polypeptide-associated complex (GO:0005854)
hemolysis by symbiont of host erythrocytes (GO:0019836)
positive regulation by symbiont of host programmed cell death (GO:0052042)
Microarray data (EDAM_data:2603)
Transcriptomics (EDAM_topic:0203)
Genes, gene family or system (EDAM_topic:0623)
N-acetyl-L-cysteine (CHEBI:28939)
Carfentrazone-ethyl (CHEBI:3416)
maleate(2-) (CHEBI:30780)
protein polypeptide chain (CHEBI:16541)
ribonucleic acid (CHEBI:33697)
oxycodone (CHEBI:7852)
opioid dependence (EFO:0005611)
total RNA (EFO:0004964)
treatment (EFO:0000727)
Illumina HiSeq 2000 (EFO:0004203)
milligram per kilogram (EFO:0002902)
obsolete_accumbens nucleus (EFO:0000906)
transcription profiling by high throughput sequencing (EFO:0002770)
transcriptome (EFO:0004421)
RNA-seq assay (MMO:0000659)
muscle structure (UBERON:0005090)
male organism (UBERON:0003101)
adult organism (UBERON:0007023)
nucleus accumbens (UBERON:0001882)
caudate-putamen (UBERON:0005383)
adult cerebral ganglion (UBERON:6110636)

Gene List • 32 Genes

Genes in threshold: 28

Uploaded As Gene Symbol Homology Score Priority LinkOuts Emphasis